The implications of Sycamore Partners’ blockbuster acquisition of WBA
The acquisition aims to reinforce Walgreens, Boots and other consumer brands by leveraging WBA’s health care expertise and Sycamore’s strength in retail.
The acquisition aims to reinforce Walgreens, Boots and other consumer brands by leveraging WBA’s health care expertise and Sycamore’s strength in retail.
Despite the overall monthly decline, six out of nine retail categories posted year-over-year gains, with online sales, health and personal care stores, and general merchandise stores leading the way.
Women consistently spend nearly 30% more out of pocket on prescriptions than men, totaling $8.5 billion more in 2024 alone.
CVS Health uses GIS technology to rapidly track weather events and support health and health care, including uninterrupted access to medications, education and resources.
Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare ecosystem. Ramakrishna is an experienced CEO and global technology leader with more than two decades of technology and business expertise
“Younger shoppers, particularly Millennials and Gen Z, are driving significant shifts in the produce industry.”
The study's authors stress that misleading promotion of medical tests can lead to overdiagnosis.
The legislation by Reps. Dunn and Mullin aims to cut red tape, expedite generic approvals, and save $800 million over a decade.
NielsenIQ reports that consumers are embracing digital-first wellness solutions at an unprecedented rate.
Remington Drug Company emphasizes importance of patient access to independent pharmacy care as FTC probe of PBMs continues.
“By whatever means, the consensus PBM reforms are long overdue and need to be enacted now. The negative impacts of inaction are mounting for Americans and for their pharmacies.”
Foundation announces $2 million in new Health Zones funding to support at-risk populations.
The RoC 35 Protocol features a comprehensive five-product morning and evening routine.
The Spiced Vanilla Lactation Latte is developed with insights from clinical research and experts.
The transaction, unanimously approved by the WBA Board of Directors, is expected to close in the fourth quarter of 2025.